DE69835010D1 - Feststellung von endometriumkrebs - Google Patents

Feststellung von endometriumkrebs

Info

Publication number
DE69835010D1
DE69835010D1 DE69835010T DE69835010T DE69835010D1 DE 69835010 D1 DE69835010 D1 DE 69835010D1 DE 69835010 T DE69835010 T DE 69835010T DE 69835010 T DE69835010 T DE 69835010T DE 69835010 D1 DE69835010 D1 DE 69835010D1
Authority
DE
Germany
Prior art keywords
finding
cancer
endometric
endometric cancer
matrix metalloproteinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69835010T
Other languages
English (en)
Other versions
DE69835010T2 (de
Inventor
Alexander Lopata
A Salamonsen
A Quinn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnotech Pty Ltd
Original Assignee
Diagnotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnotech Pty Ltd filed Critical Diagnotech Pty Ltd
Publication of DE69835010D1 publication Critical patent/DE69835010D1/de
Application granted granted Critical
Publication of DE69835010T2 publication Critical patent/DE69835010T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69835010T 1997-03-20 1998-03-20 Feststellung von endometriumkrebs Expired - Lifetime DE69835010T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO5736A AUPO573697A0 (en) 1997-03-20 1997-03-20 Diagnosis of endometrial cancer
AUPO573697 1997-03-20
PCT/AU1998/000189 WO1998042865A1 (en) 1997-03-20 1998-03-20 Detection of endometrial cancer

Publications (2)

Publication Number Publication Date
DE69835010D1 true DE69835010D1 (de) 2006-08-03
DE69835010T2 DE69835010T2 (de) 2007-06-06

Family

ID=3800039

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69835010T Expired - Lifetime DE69835010T2 (de) 1997-03-20 1998-03-20 Feststellung von endometriumkrebs

Country Status (14)

Country Link
US (1) US6607894B1 (de)
EP (1) EP0979304B1 (de)
JP (2) JP4183757B2 (de)
KR (1) KR20010006344A (de)
CN (1) CN1257550A (de)
AT (1) ATE331039T1 (de)
AU (1) AUPO573697A0 (de)
CA (1) CA2284099C (de)
DE (1) DE69835010T2 (de)
ES (1) ES2268767T3 (de)
MY (1) MY119567A (de)
NZ (1) NZ337868A (de)
WO (1) WO1998042865A1 (de)
ZA (1) ZA982403B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1066408A4 (de) * 1998-03-05 2002-09-25 Diadexus Inc Ein neuartiges verfahren zur detektion und darstellung endometrischer und uteruskrebse
AUPQ219799A0 (en) 1999-08-13 1999-09-02 R. Lurie Pty Ltd Apparatus for obtaining potological samples
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
DE10217677A1 (de) 2002-04-19 2003-11-06 Bayer Ag Verwendung von Aufhellern zur Herstellung von Streichmassen
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
US20050112622A1 (en) 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
ES2342394T3 (es) * 2004-07-23 2010-07-06 Centre De Recherche Public De La Sante Supervision de la insuficiencia cardiaca.
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
CA2595395A1 (en) * 2005-02-09 2006-08-17 Genentech, Inc. Inhibiting her2 shedding with matrix metalloprotease antagonists
WO2007086915A2 (en) * 2005-05-12 2007-08-02 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
EP2205642B1 (de) 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Nicht gerinnungshemmende polysaccharidzusammensetzungen
DK2419736T3 (da) * 2009-04-16 2014-04-22 Momenta Pharmaceuticals Inc Fremgangsmåder til vurdering af aktivitet af en polysaccharidsammensætning
BR112012001469B1 (pt) * 2009-07-24 2021-08-10 Geadic Biotec, Aie Método diagnóstico in vitro para diagnose de câncer endometrial
CN102985443B (zh) 2010-04-16 2017-05-10 动量制药公司 组织靶向
AU2011268470B2 (en) 2010-06-17 2017-02-02 Momenta Pharmaceuticals, Inc. Methods and compositions for promoting hair growth
US8455624B2 (en) * 2011-06-03 2013-06-04 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
US20130078319A1 (en) * 2011-09-22 2013-03-28 Memorial Sloan-Kettering Cancer Center Detection of ovarian cancer
DK2809801T3 (en) * 2012-01-31 2018-11-12 Speiser Paul NON-INVASIVE CANCER DIAGNOSIS
US10016449B2 (en) 2013-05-28 2018-07-10 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
WO2016000028A1 (en) * 2014-07-02 2016-01-07 Bionomics Limited Predictive biomarkers
EP3253891B1 (de) * 2015-02-06 2020-11-11 Quest Diagnostics Investments LLC Zusammensetzungen und verfahren zur bestimmung der endomentriumkrebsprognose
EP4180814A3 (de) * 2016-05-04 2023-07-12 Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca Marker für endometriumkrebs
IN202021002695A (de) 2020-01-21 2021-07-23
CN112961921B (zh) * 2021-03-26 2022-07-01 中国医学科学院北京协和医院 一种用于判断早期子宫内膜癌预后的制剂及复发风险模型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
WO1994005807A1 (en) * 1992-08-28 1994-03-17 Dickson Robert B Matrix-degrading metalloproteinase
JPH09503901A (ja) * 1992-11-16 1997-04-22 キャンサー リサーチ ファンド オブ コントラ コスタ 広範な新生物特異性を有するペプチドおよびアンチセンスペプチド

Also Published As

Publication number Publication date
AUPO573697A0 (en) 1997-04-10
ES2268767T3 (es) 2007-03-16
MY119567A (en) 2005-06-30
KR20010006344A (ko) 2001-01-26
EP0979304A4 (de) 2003-06-11
EP0979304B1 (de) 2006-06-21
CA2284099C (en) 2010-04-27
JP2002501613A (ja) 2002-01-15
EP0979304A1 (de) 2000-02-16
ATE331039T1 (de) 2006-07-15
CN1257550A (zh) 2000-06-21
JP4183757B2 (ja) 2008-11-19
JP2007202556A (ja) 2007-08-16
DE69835010T2 (de) 2007-06-06
US6607894B1 (en) 2003-08-19
ZA982403B (en) 1998-10-21
NZ337868A (en) 2002-05-31
WO1998042865A1 (en) 1998-10-01
CA2284099A1 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
DE69835010D1 (de) Feststellung von endometriumkrebs
ES2165402T3 (es) Procedimiento para la deteccion sensible de acidos nucleicos.
ATE291583T1 (de) Polymorphismus von mononukleotiden und ihre verwendung in der genanalyse
DK0749325T3 (da) Bispecifikke molekyler med klinisk anvendelse
HUP0100079A2 (hu) Új, fluoreszcens riportermolekulák és alkalmazásaik, többek között kaszpázok vizsgálatára
DE69715669T2 (de) Detektion einer genetischen prädisposition für diabetische retinopathie mit dem risiko des verlusts der sehkraft
DE3886081T2 (de) Quantitatives Analyseinstrument.
DE69932845D1 (de) Methoden zur quantifizierung von hla-dr und cd11b
ES2056790T3 (es) Ensayo para determinar la predisposicion o susceptibilidad a enfermedades asociadas con dna.
ATE80734T1 (de) Diagnostisches testverfahren eines inhibitors von plasminogen aktivatoren vom tissue- und urokinasetyp.
IL81695A (en) Quantitative determination of the degree of amplification of genes and/or corresponding messenger rna and reagent kit for performing the determination
ES2166822T3 (es) Procedimientos de seleccion de la enfermedad de crohn usando alelos de microsatelites de tnf.
DK156668C (da) Fremgangsmaade til kvantitativ bestemmelse af blodkoagulationsfaktor xii i humant plasma
SE8505458D0 (sv) Bakteriofager som igenkennings- och identifieringsmedel
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
ES2175095T3 (es) Marcadores de adn respecto al tamaño de una camada de cerdos.
DE60037864D1 (de) Enzymhemmungsimmunverfahren
DK0791073T3 (da) Analysemetode
DE3889718T2 (de) Maltooligosaccharid-Derivate und -Reagenzien für die Bestimmung von Amylase-Aktivität.
DE69710469D1 (de) Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus
EP1141703A4 (de) Verfahren zum bestimmen eines erhöhten risikos einer frau ein "down-syndrom" zu tragen
ES2149448T3 (es) Agentes terapeuticos y analiticos.
DE69840928D1 (de) Nachweismethoden für reagenzien, die das "inhibitor-der-apoptose-protein" (iap) regulieren und dadurch auf die caspaseaktivität einwirken
ES2121756T3 (es) Analisis enzimatico y equipo de analisis para medir la activacion celular.
赵右更 et al. PRENATAL DIAGNOSIS Ⅱ. AMNIOTIC FLUID ACETYLCHOLINESTERASE ISOENZYME PATTERNS AND ALPHA-FETOPROTEIN FOR PRENATAL DIAGNOSIS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition